Rep. Amy L. Grant marked excused on HB4327 audit of 340B Drug Discount Program

Rep. Amy L. Grant (R-47th) was marked as excused for HB4327, which seeks an audit of the 340B Drug Discount Program, during the 104th General Assembly on May 31, 2026, according to the Illinois House. The legislation cleared the House with a 106-8 vote.

The bill’s official language describes the initiative as: "AUDITOR GENERAL-340B AUDIT."

Below is a summary, utilizing information from the bill itself, with some interpretation to clarify key points.

This bill instructs the Illinois auditor general to conduct a thorough audit after the bill takes effect, focusing on the participation of covered entities in the federal 340B Drug Discount Program within the state. The review will examine profits from 340B drugs, expenditures on third-party administrators, payments sent to pharmacy benefit managers and contract pharmacies, drug ownership at contract pharmacy premises, typical markups on drugs under the program, and how often price discounts benefit patients in need during sales. Findings and recommendations must be reported to the General Assembly.

The final recorded measure for HB4327 read, 'Senate Committee Amendment No. 1 House Concurs.'

Grant holds a Bachelor of Science from the University of Pittsburgh, earned in 1980.

She joined the Illinois State House in 2023 as a Republican representing the 47th District, succeeding Deanne Mazzochi.

In Illinois, legislation proceeds through a multi-stage process that starts in one legislative chamber, includes committee examination, floor discussions and voting in both the House and Senate, and concludes with approval or veto by the governor. The General Assembly meets on a biennial cycle, and while thousands of bills are introduced every session, only a few advance to enactment.